Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Potential interruptions in HIV prevention and treatment services for gay, bisexual, and other men who have sex with men associated with COVID-19

Amrita Rao, Katherine Rucinski, Brooke Jarrett, Benjamin Ackerman, Sara Wallach, Julia Marcus, Tyler Adamson, Alex Garner, Glenn-Milo Santos, Chris Beyrer, Sean Howell, Stefan Baral
doi: https://doi.org/10.1101/2020.08.19.20178285
Amrita Rao
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arao24{at}jhu.edu
Katherine Rucinski
2Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brooke Jarrett
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Ackerman
3Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Wallach
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Marcus
4Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston USA
5Fenway Institute, Boston USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tyler Adamson
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Garner
6Hornet, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenn-Milo Santos
7Community Health Systems Department, University of California San Francisco, San Francisco, USA
8Center of Public Health Research, San Francisco Department of Public Health, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Beyrer
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Howell
6Hornet, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Baral
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Globally, the coronavirus pandemic has necessitated a range of population-based measures in order to stem the spread of infection and reduce COVID-19-related morbidity and mortality. These measures may be associated with disruptions to other health services including for gay, bisexual, and other men who have sex with men (MSM) at risk for or living with HIV. Here, we assess the relationship between stringency of COVID-19 mitigation strategies and interruptions to HIV prevention and treatment services for MSM.

Methods Data for this study were collected as part of a COVID-19 Disparities Survey implemented by the gay social networking app Hornet, with data collected between April 16th, 2020 and May 24th, 2020. Data were assessed for countries where at least 50 participants completed the survey, to best evaluate country-level heterogeneity. We used a modified Poisson regression model, with clustering at the country-level, to assess the association between stringency of pandemic control measures and access to HIV services. Pandemic control measures were quantified using the Oxford Government Response Tracker Stringency Index; each country received a score (0-100) based on the number and strictness of nine indicators related to school and workplace closures and travel bans.

Results A total of 10,654 MSM across 20 countries were included in these analyses. The mean age was 34.2 (standard deviation: 10.8), and 12% (1264/10540) of participants reported living with HIV. The median stringency score was 82.31 (Range:[19.44, Belarus]-[92.59, Ukraine]). For every ten-point increase in stringency, there was a 3% reduction in the prevalence of access to in-person testing (aPR: 0.97, 95% Cl:[0.96, 0.98]), a 6% reduction in the prevalence of access to self-testing (aPR: 0.94, 95% Cl:[0.93, 0.95]), and a 5% reduction in access to PrEP (aPR: 0.95, 95% Cl:[0.95, 0.97]). Among those living with HIV, close to one in five (n = 218/1105) participants reported being unable to access their provider either in-person or via telemedicine during the COVID-19 pandemic, with a greater proportion of interruptions to treatment services reported in Belarus and Mexico. Almost half (n = 820/1254) reported being unable to refill their HIV medicine prescription remotely.

Conclusions More stringent government responses were associated with decreased access to HIV diagnostic, prevention, and treatment services. To minimize increases in HIV-related morbidity and mortality, innovative strategies are needed to facilitate minimize service interruptions to MSM communities during this and potential future waves of COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors and their institutions did not at any time receive payment or services from a third party for any aspect of the submitted work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was reviewed by the Johns Hopkins School of Public Health Institutional Review Board and received a Category 4 exemption.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from Hornet but restrictions apply to the availability of these data, which are not publicly available. Data from the OxCGRT Government Response Stringency Index are publicly available through the Oxford COVID-19 Government Response Tracker online reporting systems.

https://www.bsg.ox.ac.uk/research/research-projects/coronavirus-government-response-tracker

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Potential interruptions in HIV prevention and treatment services for gay, bisexual, and other men who have sex with men associated with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Potential interruptions in HIV prevention and treatment services for gay, bisexual, and other men who have sex with men associated with COVID-19
Amrita Rao, Katherine Rucinski, Brooke Jarrett, Benjamin Ackerman, Sara Wallach, Julia Marcus, Tyler Adamson, Alex Garner, Glenn-Milo Santos, Chris Beyrer, Sean Howell, Stefan Baral
medRxiv 2020.08.19.20178285; doi: https://doi.org/10.1101/2020.08.19.20178285
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Potential interruptions in HIV prevention and treatment services for gay, bisexual, and other men who have sex with men associated with COVID-19
Amrita Rao, Katherine Rucinski, Brooke Jarrett, Benjamin Ackerman, Sara Wallach, Julia Marcus, Tyler Adamson, Alex Garner, Glenn-Milo Santos, Chris Beyrer, Sean Howell, Stefan Baral
medRxiv 2020.08.19.20178285; doi: https://doi.org/10.1101/2020.08.19.20178285

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)